Table 2. Biological characteristics of patients.
| Controls (n = 19) | Non severe PE (n = 6) | Severe PE (n = 13) | p-value | |
|---|---|---|---|---|
| Proteinuria (g/24h) | 0** | 0.38 [0.20-0.38] | 1.00 [0.53-3.00] | 0.02 |
| Uricemia (µmol/L) | 277 [196-292]* | 365 [289-384] | 336 [286-382] | 0.78 |
| Platelets (109/L) | 236 [212-259] | 209 [181-258] | 259 [229-347] | 0.22 |
| Neutrophils (109/L) | 8.2 [7.0-10.3] | 6.7 [5.3-7.0] | 9.2 [5.3-13.3] | 0.10 |
| Lymphocytes (109/L) | 2.2 [1.6-2.4] | 2.2 [1.7-2.5] | 2.1 [1.3-2.9] | 0.86 |
| Monocytes (109/L) | 0.6 [0.6-0.8] | 0.5 [0.4-0.5] | 0.6 [0.5-0.7] | 0.28 |
| ASAT (UI/L) | NA | 24 [22-27] | 21 [19-24] | 0.15 |
| ALAT (UI/L) | NA | 17 [11-21] | 16 [14-19] | 0.90 |
| LDH (UI/L) | NA | 457 [310-506] | 386 [204-540] | 1 |
The values were expressed as median and interquartile range (in brackets). As inclusion criteria for proteinuria was based on a positive urinary stick or an urine sample, one patient from the non-severe group displayed a low value on the 24h collection time proteinuria (0.13g/24h). The asterisks correspond to the comparison between controls and PE independently of the severity of the disease. The p values correspond to the comparison between non-severe and severe PE. *p < 0.01; **p < 0.001. ASAT: aspartate amino transferase; ALAT: alanine amino transferase ; LDH: lactate dehydrogenase. NA: not available.